GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 13 [WO2021188450]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome inhibitor with potential as a non-steroidal anti-inflammatory agent. It is one of the structures claimed in Zomagen Biosciences' (now part of Eli Lilly via a previous Ventyx Biosciences merger) patent WO2021188450 [1]. Evidence suggests that abdenoflast is likely the INN for the peripherally restricted NLRP3 inhibitor VTX2735 [2].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Inhibits IL-1β production in LPS-stimulated human whole blood (IC50 <1000 nM) [1]. The IC50 for inhibition of IL-1β production by LPS-stimulated mouse bone marrow derived macrophages is <100 nM. |